IGHE and agammaglobulinemia: Compatible with the immunologic features available in IUIS 2019 (2), hyper IgE and hypogammaglobulinemia was found in the majority of patients with STAT3 AD (LOF) and DNMT3B/ZBTB24 mutations, respectively.